Clinical Trial Update: Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating levocarnitine with vitamin B complex to treat hyperbilirubinemia caused by PEG-asparaginase or inotuzumab ozogamicin in acute lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Hyperbilirubinemia

Drugs mentioned

• LEVOCARNITINE (levocarnitine)
• Vitamin B complex (Vitamin B complex)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Hyperbilirubinemia | Phase 2 | Status: TERMINATED | Results posted: 2025-09-05